Operating income is expected to remain flat or decline by up to a high-single-digit percentage rate in 2023.
By 2025 Fresenius Medical Care targets to achieve an improved operating income margin of 10 to 14%.
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of €0.86 per share. This is a 4.44 percent decrease over earnings of €0.90 per share from the same period last year. The company reported €5.00